It is a chemicals and materials private limited company based in Muzaffarnagar, Uttar Pradesh, India, established in 2012.
2012 | Muzaffarnagar, Uttar Pradesh, India | ActiveKiaan Pharma Private Limited, a active private limited company, was established on 09 August 2012 in Muzaffarnagar, Uttar Pradesh, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24233UP2012PTC051891. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.20 M.
It upholds a compliant status. Its leadership includes Ganga Singh (Director), Vaishali Arpit Rajvanshi (Additional Director). Past directors included Poonam Garg, Divesh Kumar, Ganga Singh. It holds ₹4.00 M open charges and ₹6.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 67-B, New Mandi, Muzaffarnagar, Uttar Pradesh, 251001.
U24233UP2012PTC051891
051891
09 August 2012
₹2.50 M
₹2.20 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Kiaan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganga Singh | Director | 05 Feb 2024 | Current |
| Vaishali Arpit Rajvanshi | Additional Director | 23 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 22 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Aug 2018 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kiaan Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.64% decrease. The company also saw a slight improvement in profitability, with a 5.43% increase in profit. The company's net worth moved up by a moderate rise of 2.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kiaan Pharma had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹6,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2023 | Others | ₹4.00 M | Open |
| 23 May 2013 | Punjab National Bank | ₹6.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kiaan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kiaan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kiaan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vaishali Arpit Rajvanshi was appointed as a Additional Director was appointed as a Additional Director on 23 Oct 2024 & has been associated with this company since 1 year 2 months . was documented.
Progress on Kiaan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Kiaan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Ganga Singh was appointed as a Director was appointed as a Director on 05 Feb 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
A charge with Others amounted to Rs. 4.00 M with Charge ID 100727094 was registered on 23 May 2023. was recorded as a recent event.
A charge registered on 23 May 2013 via Charge ID 10428615 with Punjab National Bank was fully satisfied on 22 Apr 2014. was recorded as a recent event.
The CIN of Kiaan Pharma Private Limited is U24233UP2012PTC051891.
Kiaan Pharma Private Limited is headquartered at 67-B, New Mandi, Muzaffarnagar, Uttar Pradesh, 251001.
Kiaan Pharma Private Limited was incorporated on 09 August 2012.
The current directors of Kiaan Pharma Private Limited are
The primary industry of Kiaan Pharma Private Limited is Trade.
Kiaan Pharma Private Limited is unlisted.
The authorized capital of Kiaan Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.20 M.
The compliance status of Kiaan Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX